Taken together, the fact that TERT promoter mutations are detectable only in a small subset of cholangiocarcinoma indicates that the mechanism of telomerase activation is evidently different from telomerase activation in many HCCs (Figure 2). This evidence concerns the gene TERT and cholangiocarcinoma.